Vaccines,
Vaccine Deployment, and “New Vaccines”
(LSF SPECIAL REPORT ON VACCINATION)
August 2025
Part 3 of 5 Wednesday 27th August
Introduction to Part 3
In the last serial, yesterday, we began with the OPV our case studies of
7 popular vaccination schemes to illustrate our strong concerns with the present
status of an idea which ordinarily should have been a blessing to mankind, but
is now thoroughly corrupted. It is important to note, however, that we can
hardly put the blame for this situation on local medical personnel, or even
pharmacists. Obviously, the technology
of vaccine production is not a major topic taught in Medical School – only the
use of vaccines. So, once a product is
dubbed “vaccine” by the establishment, the average medical practitioner (not to
talk of the man on the street) has some fixed idealistic expectations. A key take-away from this article is that
mere pronouncements by some “global authority” cannot transform a dog into a
baboon! No amount of technical jargons
can white-wash the horrible reality on ground: our erstwhile well-established
local vaccine production capacity was rudely sabotaged, and vaccine products,
PROSCRIBED for use in their continent of origin are now shipped to us. For mass
deployment in our children. Haba!
In today’s third serial, we address the incredible ongoing practice of
vaccines being deliberately laced with mercury, a known deadly neurotoxin. A
related practice combines together up to 5 different vaccines, and administer
them as one “new vaccine” to children. Whereas
the individual vaccines had been developed and tested for safety as separate
entities! Again, these new products are
good enough only for children in third world countries – chiefly Nigeria. How
can all these be ever justifiable?
Please read and share.
==============================================================
ii. Thimerosal
Containing-Vaccines (TCV)
Another
category of vaccines exclusively shipped to developing nations for their use,
but which are proscribed for use in the western nations producing them, are the
so-called Thimerosal-Containing Vaccines (TCVs). For this class of vaccines,
thimerosal is used as a preservative that allows multiple doses to be put in a single
vial. The doses can then be drawn from
the vial, with little fear of contamination with repeated access. Thimerosal is, however, a deadly chemical
comprised of 49.6% of highly toxic ethyl mercury. Even at minute trace levels, mercury in any
form, is known to be a deadly neurotoxicant, affecting brain function and
development; as well as causing other health problems including sterility and
kidney problems.
The United
States, on Tuesday July 22 2025, banned thimerosal, from all U.S. vaccines citing
its potential neurotoxicity risks. This
is a bold move that the US had been scared to make for two decades, principally
on concerns that it might jerk awake, developing countries who are the main
recipients of mercury-laced vaccines produced for them by the developed
nations. [Watch the announcement of the extensive justification of the US ban
at https://www.youtube.com/watch?v=PvzUjHFI9l0&t=4s]
Actually, in
the United States, mercury had been proscribed in all vaccines, except the Haemophilia
B vaccine, since 2001. For the haemophilia B (Hib, or simply flu) vaccine, a
mercury-free version is also made available together with the mercuric
version. For the rest of western
nations, all mercury-containing vaccines have been proscribed for more than 30
years. The major concerns are the well-established
adverse effects associated with even extremely low level of mercury on brain
development in babies.
Nigeria’s
health authorities are well aware of the deadly nature of mercury, and would
not tolerate even the minutest level of this chemical in soaps and cosmetics. The fear is that the chemcial could somehow
reach babies in the womb of pregnant women who may use these products [19]. Incredibly however, the very same deadly
product is welcome in the vaccines that are injected directly into these same
babies. The tacit endorsement given by
the World Health Organization to supposed indigent nations, is waved by the
Nigerian authority as the licence for perpetuating this heinous atrocity.[19] As at the present time, three major vaccines
on the routine childhood immunization schedule in Nigeria contain mercury. These include the Tetanus-Diphtera (or
alternatively, the Diphtera-Tetanus-Pertussis) vaccine, the Hepatitis B vaccine,
and the Flu (Hib) vaccine. The Hep B
vaccine is administered to totally helpless babies at birth! [16]
In
announcing the ban of all mercury-containing vaccines in the US, the Secretary
to the Department of Health and Human Services, Mr Robert F. Kennedy, made a passionate
appeal to the global health authorities sponsoring mercuric vaccines in
developing countries, saying:
“Now
that the US has removed mercury from all vaccines, we urge global health
authorities to follow suit for the protection of children around the world. We
urge the World Health Organization and GAVI to stop their programs of injecting
mercury into more than 100 million black and brown babies in developing
countries annually….” [20]
It is
doubtful these global bodies will heed this call which would certainly disrupt
a thriving global vaccine industry. It
is left for Nigerians to put pressure on the government to free Nigeria’s
babies from this wicked brain-damaging, destiny-destroying practice.
To read details
of the case against Thimerosal-Containing Vaccines, check reference [21]
iii. Mixed
Combination Vaccines
Apart from
use of mercury preservative, another class of vaccines prepared almost
exclusively for use in the so-called Low and Medium-Income countries like
Nigeria is combination vaccines. These new
vaccines comprise of several traditional vaccines combined and administered
together in one shot. For instance, the Pentavalent
vaccine combines DTP, Hep B, and the Hib traditional vaccines. The DTP vaccine itself is the combination of
diphteria, tetanus, and pertussis vaccines, which were developed and trialed as
separate entities. The main objective for
this combination arrangement is to increase vaccine uptakes, especially in the
wake of new vaccines being continually added to the childhood schedules. However, the vaccines were not originally
developed for use in this “combination” format, and it should not be surprising
the myriads of adverse issues that have been associated with the practice.
A landmark
research funded by the Danish government, “examined the introduction of
diphtheria-tetanus-pertussis (DTP) and oral polio vaccine (OPV) in an urban
community in Guinea-Bissau in the early 1980s”.
The study reported that unvaccinated children had far better health
indices than those vaccinated! According
to the paper, “The negative effect was particularly strong for children who had
received DTP only and no OPV”. It also
noted that “All-cause infant mortality after 3 months of age increased after
the introduction of these vaccines”.[22]
A 2012
paper in the Archives of Disease in Childhood reported that: “Studies
from low-income countries have suggested that diphtheria-tetanus-pertussis
(DTP) vaccine provided after Bacille Calmette-Guerin (BCG) vaccination may have
a negative effect on female survival.”
The study then went on to confirm that girls who received DTP after BCG
had a significantly increased death rate ratio (DRR) of as high as 5.68,
compared with unvaccinated girls. [23].
Despite such a finding, the Nigerian vaccine schedule still requires
babies to receive BCG at birth, followed by DTP six weeks later [16].
The
general explanation indicated by the results of vaccinated subjects having
worse health outcomes (including higher “all-cause mortality”) than
unvaccinated subjects, is that even though a vaccine might be providing relatively
positive outcome for the particular disease it was developed for, it invariably
could be having overall deleterious effects on the general immunity status of
the recipients, thereby making them more susceptible to other diseases. Clearly, therefore, the justification for vaccines
to be routinely administered should be evaluated holistically, not just with
respect to a particular disease. It is
clear that better outcomes will result if vaccines are rationally deployed,
with contra-indicated factors carefully considered; rather than blind, mass vaccination of all
subjects available using one-size-fits-all protocols.
The
performance of these new combination vaccines is perhaps best summarized with the
following reports of Adverse Effects Following Immunization (AEFI), taken from
“Extract from report of GACVS meeting of 12-13 June 2013, published in the
WHO Weekly Epidemiological Record on 19 July 2013”: [24]
“Four
countries that introduced pentavalent vaccines from 3 different manufacturers
presented their experience:
(1)
Sri Lanka introduced the pentavalent vaccine from Crucell in January 2008.
Within 3 months, 4 reports of deaths and 24 reports of suspected
hypotonic-hyporesponsive episodes prompted regulatory attention and
precautionary suspension of the initial vaccine lot. A subsequent death that
occurred with the next lot in April 2009 led the authorities to suspend
pentavalent vaccine use and resume DTwP and hepatitis B vaccination.
(2)
Bhutan introduced pentavalent vaccine from Panacea in September 2009. The
identification of 5 cases with encephalopathy and/or meningoencephalitis
shortly after pentavalent vaccination prompted the authorities to suspend
vaccination on 23 October 2009. Subsequently, 4 additional serious cases
related to vaccine administered prior to suspension were identified and
investigated.
(3)
India introduced pentavalent vaccine from the Serum Institute of India in the
states of Tamil Nadu and Kerala in December 2011…. To date, 83 AEFI cases, some
of which were associated with mortality, have been reported after vaccine
introduction from some states.
(4)
Vietnam introduced pentavalent vaccine from Crucell in June 2010. Through May
2013, a total of 43 serious AEFI cases were investigated, including 27 with a
fatal outcome. Following receipt of reports of 9 deaths following vaccination
between December 2012 and March 2013, health authorities suspended use of the
vaccine.
(https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/pentavalent-vaccine)
Despite
these established negative outcomes, the vaccine remains in use till
today. The Report ascribes this to “actively
managed public communication about the observed events and their public health
implications.” As seen in Table 1, this same pentavalent vaccine still features
prominently on the Nigerian childhood immunization schedule at the present time
(at weeks 6, 10, and 14).
In
closing, we might also mention here another notorious form of this unscrupulous
mixing of vaccines - recommended specifically for the “low and medium-income
countries” (LMIC). This is the
“Mix-and-Match” protocol recommended by the WHO with respect to mRNA COVID
vaccines in the heights of the COVID debacle [25]. The protocol encourages people from LMICs to
freely mix their uptake of COVID vaccines by receiving whichever brands were
available to them at any particular point in time – as “generously donated” by
western countries. In short, the WHO
bold-facedly endorsed that subjects from LMIC could take a first dose with one
brand of vaccine, and take subsequent doses with other brands! This is outrageous, as clearly, there have
been no clinical trials ascertaining the safety or efficacy of such
combinations!
20.
https://churcharise.blogspot.com/2025/08/united-states-bans-last-remaining.html
21.
https://childrenshealthdefense.org/defender/rfk-jr-slams-guardian-false-claims-thimerosal-vaccines/
22.
The Introduction of Diphtheria-Tetanus-Pertussis and Oral Polio Vaccine Among Young
Infants in an Urban African Community: A Natural Experiment Søren Wengel
Mogensena,1, Andreas Andersenb,1, Amabelia Rodriguesa, Christine S Bennb,c,
Peter Aabya,b,⁎ EBioMedicine 17 (2017)
192–198
23.
Aaby P, Ravn H, Roth A, et al, Early
diphtheria-tetanus-pertussis vaccination associated with higher female
mortality and no difference in male mortality in a cohort of low birthweight
children: an observational study within a randomised trial. Archives of Disease in Childhood 2012;97:685-691.]
24. https://churcharise.blogspot.com/2023/05/pertinent-considerations-as-we.html
No comments:
Post a Comment